Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study

Journal of Andrology

Volumn 23, Issue 3, 2002, Pages 419-425

  Von Eckardstein, Sigrid ^a   Nieschlag, Eberhard ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Injectable testosterone undecanoate; Substitution of male hypogonadism

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; STEADY STATE; TESTOSTERONE BLOOD LEVEL;

ADULT; BODY WEIGHT; DIHYDROTESTOSTERONE; EJACULATION; ESTRADIOL; FOLLICLE STIMULATING HORMONE; HEMATOCRIT; HUMANS; HYPOGONADISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PENILE ERECTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; TESTOSTERONE;

EID: 0036220738     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls
2. Potential of testosterone buciclate for male contraception: Endocrine differences between responders and nonresponders
3. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: Phase I studies
4. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years
5. Diagnosis of male infertility and hypogonadism
6. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men
7. A ten-year safety study of the oral androgen testosterone undecanoate
8. Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis
9. Effects of androgen deficiency and replacement on prostate zonal volumes
10. Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men
11. Intramuscular testosterone undecanoate with or without oral levonorgestrel: A randomized placebo-controlled feasibility study for male contraception
12. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception
13. Therapeutic controversy VII: If T, which T? Which androgen regimen should be used for supplementation in older men? Formulation, dosing and monitoring issues
14. Repeated intramuscular injections of testosterone undecanoate for substitution therapy of male hypogonadism
15. Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthate
16. Effects of testosterone replacement in hypogonadal men
17. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men
18. Differences in reproductive endocrinology between Asian men and Caucasian men - A literature review
19. A critical evaluation of simple methods for the estimation of free testosterone in serum
20. Androgens, cardiovascular risk factors and atherosclerosis
21. Testosterone replacement therapy improves mood in hypogonadal men - A clinical research center study
22. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men
23. Testosterone levels in healthy men and the relation to behavioural and physical characteristics: Facts and constructs
24. The CAG repeat polymorphism in the androgen receptor gene affects high density lipoprotein cholesterol and arterial vasoreactivity